Alex John London
Director, Center for Ethics and Policy
K&L Gates Professor of Ethics and Computational Technologies, Philosophy
Bio
Alex John London is the K&L Gates Professor of Ethics and Computational Technologies, co-lead of the K&L Gates Initiative in Ethics and Computational Technologies at Carnegie Mellon University, Director of the Center for Ethics and Policy at Carnegie Mellon University, and Chief Ethicist at the Block Center for Technology and Society at Carnegie Mellon University. An elected Fellow of the Hastings Center, Professor London’s work focuses on ethical and policy issues surrounding the development and deployment of novel technologies in medicine, biotechnology
Professor London is a member of the World Health Organization (WHO) Expert Group on Ethics and Governance of AI whose “Guidance on Large Multi-Modal Models” was published in 2024 and whose report, “Ethics and governance of artificial intelligence for health” was published in 2021. From 2022–2023 he was a member of the U.S. National Academy of Medicine Committee on Creating a Framework for Emerging Science, Technology, and Innovation in Health and Medicine, whose report "Toward Equitable Innovation in Health and Medicine: A Framework” was published in 2023. He is a conference program co-chair for the 6th AAAI / ACM Conference on Artificial Intelligence, Ethics and Society (AIES) and a member of the program committee for the 2023 ACM Conference on Fairness, Accountability, and Transparency (FAccT) conference. He has served on previous program committees for AIE in 2021 and 2022 and from 2017-2019 he was a judge for the IBM Watson AI X-Prize. He is currently a co-leader of the ethics core for the NSF AI Institute for Collaborative Assistance and Responsive Interaction for Networked Groups (AI-CARING).
For more than a decade, Professor London has helped to shape key ethical guidelines for the oversight of research with human participants. He is currently a member of the U.S. National Science Advisory Board for Biosecurity (NSABB). From 2012-2016 he was a member of the Working Group on the Revision of CIOMS 2002 International Ethical Guidelines for Biomedical Research Involving Human Subjects. Prior to